MAIA Biotechnology financial statements

마이어 바이오테크놀로지NYSEAMERICAN:MAIA · NYSE Amex · Healthcare · sector #13
$1.18-0.84%
2026-10-05 close

MAIA Biotechnology's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$17M.

Reported results

MAIA Biotechnology notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q